KOOP should have enough juice to sustain it through the early going, particularly with a strong PR wave behind it. What happens down the road will be determined by how well the company is financially managed, its partnerships and particularly its performance in relationship to its clinetele.
A subscriber to Dr. Koop.com for the past few months (not one month as a previous poster alluded KOOP has existed), I find it a useful tool for delivery of medical information. I don't read it every day. But I don't delete it either. I usually save the issues and read them lumped together in a single setting. I don't know of any online advertiser who wouldn't like to have someone sitting at a computer reading in this manner--a perfectly captured demographic target!
KOOP, by its very nature, should do well.
Nothwithstanding shorting considerations, offshore or here in the USA, I suspect there's a strong initiative on the part of some to keep the KOOP depressed as low as possible so as to accumulate more shares for what could become a lucrative ride upward. And it's also very true neither AOL, Yahoo, Amazon, Ebay or others of similar ilk had great earnings power, but performed quite nicely as a stock trading upward, often seemingly in record-breaking performance.
I'm betting KOOP's share price will rise near-term, and possibly hold well long-term. I've been wrong before; but I've also been right. Good luck, folks! |
